Marius Pearson
Oxford PharmaGenesis continued to demonstrate its leadership position in medical publications, as Chief Operating Officer, Dr Richard White served as Chairman for the second successive year at the 17th Annual Meeting of The International Publication Planning Association (TIPPA), held in San Diego, CA, USA on 5–6 February 2018.
PharmaGenesis Cardiff introduced the concept of HealthScience communications for the first time in the Middle East region, presenting on behalf of the Oxford PharmaGenesis Group at the Arab Health Congress (29 January–1 February 2018, Dubai, UAE).
Oxford PharmaGenesis is celebrating Rare Disease Day, which aims to raise awareness of rare diseases and their impact on patients’ lives.
We are delighted to announce that Martin Callaghan has joined us this week in the role of Director of Digital Communications.
Oxford PharmaGenesis had a healthy presence at the 2018 European Meeting of the International Society for Medical Publication Professionals (ISMPP) this year.
Almost 200 colleagues from around the world gathered at St Catherine’s College, Oxford, last week to celebrate the 20th anniversary of Oxford PharmaGenesis and to reflect on our success.
The desire to make a difference in the world is at the heart of everything we do at Oxford PharmaGenesis.
Oxford PharmaGenesis recently attended the 8th annual World Orphan Drug Congress (WODC) in Barcelona, which highlighted the importance of early and effective collaboration and communication between patients and other healthcare stakeholders, particularly in the rare disease space.
We were busy at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress in Glasgow last month.
It’s hard to believe that it’s only 12 months since Oxford PharmaGenesis officially launched its Patient Engagement Practice at the 2016 eyeforpharma Patient Summit.
